Application of Managed Entry Agreements for Innovative Therapies in Different Settings and Combinations: A Feasibility Analysis

The reimbursement of expensive, innovative therapies poses a challenge to healthcare systems. This study investigated the feasibility of managed entry agreements (MEAs) for innovative therapies in different settings and combinations. First, a systematic literature review included studies describing...

Descripción completa

Detalles Bibliográficos
Autores principales: A Vreman, Rick, F Broekhoff, Thomas, GM Leufkens, Hubert, K Mantel-Teeuwisse, Aukje, G Goettsch, Wim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698033/
https://www.ncbi.nlm.nih.gov/pubmed/33182732
http://dx.doi.org/10.3390/ijerph17228309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7698033/
https://www.ncbi.nlm.nih.gov/pubmed/33182732
http://dx.doi.org/10.3390/ijerph17228309

Ejemplares similares